|
BCLI Brainstorm Cell Therapeutics Inc 1137883 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-2,127,000.00 |
| Balance Sheet |
|
Current Assets
|
$184,000.00 |
|
Assets
|
$755,000.00 |
|
Current Liabilities
|
$11,764,000.00 |
|
Liabilities
|
$11,764,000.00 |
|
Equity
|
$-11,009,000.00 |
|
Shares Out
|
11034775.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-1,320,000.00 |
|
Investing Cash Flow
|
$12,000.00 |
| Market Analysis |
Market Cap
|
$10,151,993.00 |
|
Price
|
$0.88 |
|
PB
|
0.82 |
|
EPS
|
-0.19 |
|
FCF
|
$-1,338,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:45 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:45 |
|
| Apr |
May |
Jun |
| 2026-03-31 |
-1.11 |
|
|
|
|
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-14 |
-0.34 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-14 |
-0.19 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view BCLI documents filed with the SEC.
BCLI Filings
Clear
